Home › Trials › NCT06634277
Clinical trial No longer in our active list Interventional Ages 18 and up

Implementing a patient navigation program for opioid use disorder treatment

Official title: Implementing a Patient Navigation Intervention Across a Health System to Address Treatment Entry Inequities

Run by Friends Research Institute, Inc. · NCT06634277 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying out a new support program to help people with opioid use disorder get the treatment they need after leaving the hospital, especially focusing on helping those from racial minority groups.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment32 (estimated)
SponsorFriends Research Institute, Inc.
Academic / other
Locations2 sites (Philadelphia, Pennsylvania and 1 other locations)
Trial IDNCT06634277 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 or older who meet the DSM-5 criteria for moderate to severe opioid use disorder.

Probably not a fit

Patients who have been enrolled in opioid use disorder treatment within 30 days prior to hospitalization or those residing outside the City of Philadelphia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to implement the NavSTAR patient navigation intervention for individuals with opioid use disorder (OUD) following hospitalization. By engaging community, hospital, and patient partners, the study seeks to address barriers to accessing treatment, particularly for racial minority groups. The intervention will be piloted in a health system to assess its feasibility, reach, and sustainability, building on previous findings that demonstrated its effectiveness in increasing treatment entry and reducing hospital readmissions. The study employs a hybrid implementation-effectiveness design to bridge the gap between research and practice.

Why it matters

Potential benefit: If successful, this intervention could significantly improve access to opioid use disorder treatment and reduce overdose rates among vulnerable populations.

How similar studies have gone: Previous studies have shown success with similar patient navigation interventions, indicating potential for effective implementation in real-world settings.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion criteria:

1. age 18 or older;
2. current DSM-5 criteria for moderate to severe OUD;
3. willing and able to provide informed consent in English.

Exclusion criteria:

1. enrollment in OUD treatment 30-days prior to hospitalization;
2. residency outside the City of Philadelphia;
3. pregnancy;
4. planned discharge to a long-term inpatient care facility (e.g., hospice);
5. hospitalization for a suicide attempt.

Where it's running

  • Jefferson Health
    Philadelphia, Pennsylvania, United States     Recruiting
  • Friends Research Institute
    Philadelphia, Pennsylvania, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Opioid Use Disorder 579Friends Research Institute, INC. 30
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.